05:09 PM EDT, 06/11/2025 (MT Newswires) -- Eterna Therapeutics (ERNA) filed a registration statement on Wednesday for the resale of about 57 million common shares by certain selling shareholders.

The company said 47.7 million shares are issued and outstanding, while the remaining are issuable on exercise of pre-funded warrants at an exercise price of $0.005.

Eterna will not receive any proceeds from the sale of shares.